FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2497082852> ?p ?o ?g. }

• W2497082852 abstract "Introduction: Mutations in ras genes that result in constitutive activation of Ras proteins are key drivers of oncogenesis, but no effective drugs have been developed that target these aberrant gene products. Through iterative screening and chemical optimization using a phenotypic assay designed to select for Ras inhibitors, we identified a novel series of compounds that potently and selectively inhibit the growth of tumor cells harboring activated Ras relative to cells lacking activated Ras. Several compounds in the series have favorable drug-like properties with strong antitumor activity in a mouse K-Ras mutant tumor model. Methods: Viable cell number was measured using a luminescent indicator of ATP. Disruption of Ras-Raf binding was determined by pre-incubating GST-Raf beads with cell lysates in the presence of test compounds for 30 min. Ras activation was measured by Ras pull-down and western blotting using an anti-Ras antibody. Cell cycle arrest was measured by DNA content. Antitumor activity was determined in a subcutaneous mouse tumor model involving K-Ras mutant HCT116 colon tumors. Mice were treated with Ras inhibitors administered ip for 14 days bid at a dose of 2.5 or 5 mg/kg. Results: Low nanomolar concentrations of DC070-547 inhibited the growth of multiple tumor cell lines harboring activated K-Ras, N-Ras or H-Ras with a selectivity index greater than 100-fold over cells lacking activated Ras. Ras selectivity was confirmed by transfecting human HT29 colon and H322 lung tumor cells that lack activated Ras with mutant H-Ras, thus inducing sensitivity to DC070-547. The compound also inhibited Ras-Raf binding as evident by Ras-pull down assays of lysates from tumor cells treated with DC070-0547 at concentrations that inhibit tumor cell growth. DC070-547 caused G2 phase cell cycle arrest and induced apoptosis selectively in tumor cells containing activated Ras. Cultured epithelial cells derived from normal colon, mammary, and lung tissues were essentially refractory to treatment.The Ras inhibitors were evaluated for antitumor activity in a subcutaneous mouse model involving K-Ras mutant human HCT116 colon tumors. Treatments were well tolerated and completely suppressed tumor growth with the effect being sustained for at least six weeks after treatment was discontinued. Complete tumor regression was also apparent in some of the treated mice. Conclusion: While Ras is widely considered to be non-druggable, we have identified a novel series of compounds that potently and selectivity inhibit the growth of tumor cells harboring activated Ras. With promising drug-like properties, these compounds represent a first in class series of Ras inhibitors from which several prospective drug development candidates have been identified.. These results support further preclinical development and future Phase I/II clinical evaluation in patients with Ras-driven cancers. Citation Format: Adam B. Keeton, Bing Zhu, Kevin J. Lee, Joshua C. Canzoneri, Sara C. Sigler, Ashley S. Lindsey, Veronica Ramirez-Alcantara, Luciana Barnes, Tyler E. Mattox, Kate McConnell, Kristy L. Berry, Jacob Valiyaveettil, Xi Chen, Michael R. Boyd, Gary A. Piazza. Discovery and in vitro and in vivo characterization of a novel, small-molecule Ras inhibitor class. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 326." @default.
• W2497082852 created "2016-08-23" @default.
• W2497082852 creator A5003328681 @default.
• W2497082852 creator A5003532686 @default.
• W2497082852 creator A5008171524 @default.
• W2497082852 creator A5008726864 @default.
• W2497082852 creator A5031656411 @default.
• W2497082852 creator A5033180353 @default.
• W2497082852 creator A5034358215 @default.
• W2497082852 creator A5036206395 @default.
• W2497082852 creator A5036693985 @default.
• W2497082852 creator A5043335237 @default.
• W2497082852 creator A5049009941 @default.
• W2497082852 creator A5062264366 @default.
• W2497082852 creator A5071802884 @default.
• W2497082852 creator A5083142610 @default.
• W2497082852 creator A5086841234 @default.
• W2497082852 date "2016-07-15" @default.
• W2497082852 modified "2023-10-18" @default.
• W2497082852 title "Abstract 326: Discovery and in vitro and in vivo characterization of a novel, small-molecule Ras inhibitor class" @default.
• W2497082852 doi "https://doi.org/10.1158/1538-7445.am2016-326" @default.
• W2497082852 hasPublicationYear "2016" @default.
• W2497082852 type Work @default.
• W2497082852 sameAs 2497082852 @default.
• W2497082852 citedByCount "0" @default.
• W2497082852 crossrefType "proceedings-article" @default.
• W2497082852 hasAuthorship W2497082852A5003328681 @default.
• W2497082852 hasAuthorship W2497082852A5003532686 @default.
• W2497082852 hasAuthorship W2497082852A5008171524 @default.
• W2497082852 hasAuthorship W2497082852A5008726864 @default.
• W2497082852 hasAuthorship W2497082852A5031656411 @default.
• W2497082852 hasAuthorship W2497082852A5033180353 @default.
• W2497082852 hasAuthorship W2497082852A5034358215 @default.
• W2497082852 hasAuthorship W2497082852A5036206395 @default.
• W2497082852 hasAuthorship W2497082852A5036693985 @default.
• W2497082852 hasAuthorship W2497082852A5043335237 @default.
• W2497082852 hasAuthorship W2497082852A5049009941 @default.
• W2497082852 hasAuthorship W2497082852A5062264366 @default.
• W2497082852 hasAuthorship W2497082852A5071802884 @default.
• W2497082852 hasAuthorship W2497082852A5083142610 @default.
• W2497082852 hasAuthorship W2497082852A5086841234 @default.
• W2497082852 hasConcept C104317684 @default.
• W2497082852 hasConcept C143065580 @default.
• W2497082852 hasConcept C153911025 @default.
• W2497082852 hasConcept C185592680 @default.
• W2497082852 hasConcept C202751555 @default.
• W2497082852 hasConcept C207001950 @default.
• W2497082852 hasConcept C502942594 @default.
• W2497082852 hasConcept C54355233 @default.
• W2497082852 hasConcept C55493867 @default.
• W2497082852 hasConcept C555283112 @default.
• W2497082852 hasConcept C62112901 @default.
• W2497082852 hasConcept C81885089 @default.
• W2497082852 hasConcept C85265743 @default.
• W2497082852 hasConcept C86803240 @default.
• W2497082852 hasConceptScore W2497082852C104317684 @default.
• W2497082852 hasConceptScore W2497082852C143065580 @default.
• W2497082852 hasConceptScore W2497082852C153911025 @default.
• W2497082852 hasConceptScore W2497082852C185592680 @default.
• W2497082852 hasConceptScore W2497082852C202751555 @default.
• W2497082852 hasConceptScore W2497082852C207001950 @default.
• W2497082852 hasConceptScore W2497082852C502942594 @default.
• W2497082852 hasConceptScore W2497082852C54355233 @default.
• W2497082852 hasConceptScore W2497082852C55493867 @default.
• W2497082852 hasConceptScore W2497082852C555283112 @default.
• W2497082852 hasConceptScore W2497082852C62112901 @default.
• W2497082852 hasConceptScore W2497082852C81885089 @default.
• W2497082852 hasConceptScore W2497082852C85265743 @default.
• W2497082852 hasConceptScore W2497082852C86803240 @default.
• W2497082852 hasLocation W24970828521 @default.
• W2497082852 hasOpenAccess W2497082852 @default.
• W2497082852 hasPrimaryLocation W24970828521 @default.
• W2497082852 hasRelatedWork W1558058709 @default.
• W2497082852 hasRelatedWork W1565657149 @default.
• W2497082852 hasRelatedWork W2039575680 @default.
• W2497082852 hasRelatedWork W2064918473 @default.
• W2497082852 hasRelatedWork W2070656334 @default.
• W2497082852 hasRelatedWork W2074867181 @default.
• W2497082852 hasRelatedWork W2089553218 @default.
• W2497082852 hasRelatedWork W2134829792 @default.
• W2497082852 hasRelatedWork W2159486281 @default.
• W2497082852 hasRelatedWork W2260428309 @default.
• W2497082852 hasRelatedWork W2292209469 @default.
• W2497082852 hasRelatedWork W2342485020 @default.
• W2497082852 hasRelatedWork W2394658402 @default.
• W2497082852 hasRelatedWork W2484567797 @default.
• W2497082852 hasRelatedWork W2487842402 @default.
• W2497082852 hasRelatedWork W2499892494 @default.
• W2497082852 hasRelatedWork W2506939522 @default.
• W2497082852 hasRelatedWork W2563423406 @default.
• W2497082852 hasRelatedWork W2953646893 @default.
• W2497082852 hasRelatedWork W2980191829 @default.
• W2497082852 isParatext "false" @default.
• W2497082852 isRetracted "false" @default.
• W2497082852 magId "2497082852" @default.
• W2497082852 workType "article" @default.